2Lemos JA, Blazing MA, Wiviott SD, et al. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes : phase z of the A xo z triM. JAMA, 2004,292:1 307 -1 316.
3Prevention of cardiovascular events and death with pravastain in patients with coronary heart disease and abroad range of initial cholesterol levels. The Long- Term Intervention with Pravastalin in Ischameic Disease Study Group. N Eng J, 1998,339:1 349 - 1 357.
4方圻.中国成人血脂异常防治指南.北京:人民出版社,2007.65-71.
5Maron DJ, Fazio S, Linton MF. Current perspectives on statins. Circulation,2000,101:207 - 213.
6赵水平,著.他汀治疗学.南京:中南大学出版社,2005,201-243.
二级参考文献20
1Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lance,1994, 344:1383-1389.
2Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J, 2004, 350:1495-1504.
3Murphy SA, Cannon CP, Wiviott SD, et al. Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome ( a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials). Am J Cardiol, 2007,100:1047- 1051.
4Silva M, Matthews MI, Jarvis C, et al. Meta-analysis of druginduced adverse events associated with intensive-dose statin therapy. Clin Ther, 2007, 29 : 253-260.
5Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation, 1998,97:1440-1445.
6Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J, 1996, 335:1001-1009.
7Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Isehaemie Disease (LIPID) Study Group. N Engl J, 1998,339 : 1349-1357.
8Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial Lancet, 2002,360:7-22.
9Schwartz GG, Olsson AG, Ezekowitz MD, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA, 2001,285 : 1711-1718.
10de Lemos JA, Blazing MA, Wiviott SD, et al. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. JAMA, 2004, 292:1307-1316.
1Luo Y,Jiang DY.Changes in serum interleukin-6 and high-sensitivity C-reaction protein levels in patients with acute coronary syndeome and their responses to simvastatin[J].Heart Vessels,2004,19 (6):257-262.
2Tonstad S,Sundfor T,Seljeflot I.Effect of lifestyle changes on atherogenic lipids and endothelial cell adhesion molecules in young adults with familial premature coronary heart disease[J].Am J Cardiol,2005,95(10):1187-1191.
3Yusuf S,Hawken S,Upau S,et al.Obesity and the risk of myocardial infarctian in 27,000 participants from 52 countries,a case-controlled study[J].Lancet,2005,366(9497):1640-1649.
